Global S&T Development Trend Analysis Platform of Resources and Environment
CRISPR, the revolutionary genetic ‘scissors,’ honored by Chemistry Nobel | |
admin | |
2020-10-07 | |
发布年 | 2020 |
语种 | 英语 |
国家 | 美国 |
领域 | 资源环境 |
正文(英文) | This year’s Nobel Prize in Chemistry has been awarded to two scientists who transformed an obscure bacterial immune mechanism, commonly called CRISPR, into a tool that can simply and cheaply edit the genomes of everything from wheat to mosquitoes to humans. The award went jointly to Emmanuelle Charpentier of the Max Planck Unit for the Science of Pathogens and Jennifer Doudna of the University of California, Berkeley, “for the development of a method for genome editing.” They first showed that CRISPR—which stands for clustered regularly interspaced short palindromic repeats—could edit DNA in an in vitro system in a paper published in the 28 June 2012 issue of Science. Their discovery was rapidly expanded on by many others and soon made CRISPR a common tool in labs around the world. The genome editor spawned industries working on making new medicines, agricultural products, and ways to control pests. Many scientists anticipated that Feng Zhang of the Broad Institute, who showed 6 months later that CRISPR worked in mammalian cells, would share the prize. The institutions of the three scientists are locked in a fierce patent battle over who deserves the intellectual property rights to CRISPR’s discovery, which some estimate could be worth billions of dollars. Chemistry Nobel: CRISPR“The ability to cut DNA where you want has revolutionized the life sciences. The genetic scissors were discovered 8 years ago, but have already benefited humankind greatly,” Pernilla Wittung Stafshede, a chemical biologist at the Chalmers University of Technology, said at the prize briefing. CRISPR was also used in one of the most controversial biomedical experiments of the past decade, when a Chinese scientist edited the genomes of human embryos, resulting in the birth of three babies with altered genes. He was widely condemned and eventually sentenced to jail in China, a country that has become a leader in other areas of CRISPR research. Although scientists were not surprised Doudna and Charpentier won the prize, Charpentier was stunned. “As much as I have been awarded a number of prizes, it’s something you hear, but you don’t completely connect,” she said in a phone call with the Nobel Prize officials. “I was told a number of times that when it happens, you’re very surprised and feel that it’s not real.” At a press briefing today, Doudna noted she was asleep and missed the initial calls from Sweden, only waking up to answer the phone finally when a Nature reporter called. "She wanted to know if I could comment on the Nobel and I said, Well, who won it? And she was shocked that she was the person to tell me." No previous science Nobel has been given to two women only. "It’s great for especially younger women to see this and to see that women’s work can be can be recognized, as much as men’s," Doudna said. "I think for many women, there’s a feeling that no matter what they do, their work will never be recognized as it might be if they were a man. And I’d like to see that change, of course, and I think this is a step in the right direction." Doudna added that she used to get puzzled looks when she said she worked on a bacterial immune system. Bacteria use the original form of CRISPR to fend off viruses, slicing up their DNA. “I am so pleased that the [Nobel] award description led off with the bacterial adaptive immune response, which is a truly amazing system, thus highlighting how basic research is absolutely critical for medical applications,” says CRISPR researcher Maria Jasin of the Sloan Kettering Institute. Doudna and Charpentier—who is originally from France and at the time of the discovery worked at Umeå University—showed they could program a small strip of what they called “guide RNA” to carry a bacterial CRISPR-associated (Cas) enzyme to exact DNA sequences, allowing them to target specific genes. Cas then cuts the double-stranded DNA. In many cases, the DNA repair mechanism of the cell makes errors, which can cripple a gene—knocking out a gene in this fashion is an effective way to study its normal role. CRISPR also allows researchers to insert a new stretch of DNA at the cut site.
Harvard University chemist George Church says the Nobel Committee made “a really great choice.” Church published a study showing CRISPR could edit mammalian cells at the same time as Zhang, who previously was a postdoc in his lab. But Church doesn’t think either of them were slighted by not being included in the prize. As he sees it, Charpentier and Doudna made a discovery, which is what the committee prefers to reward, and he and Zhang were inventors. “If anyone wants any tips on how not win a Nobel Prize, it’s pretty easy,” Church says. “I’ve carefully avoided all this kind of brouhaha by focusing on inventions.” And, he says, Zhang is young. “Feng Zhang is so full of creative ideas that I have no doubt that he will get one or two in the future.” Erik Sontheimer, a CRISPR researcher at the University of Massachusetts Medical School, also endorses the Nobel committee decision. “The prize is not based on anything related to patent law,” he says. He called Zhang being excluded “appropriate,” noting that several other researchers, including Zhang’s main collaborators and Church, helped show CRISPR could edit mammalian cells at roughly the same time. “I don’t see that it would have been legitimate to single him out. It’s always the case that there will be pieces [of a scientific advance] that cannot be recognized.” Tom Welton, president of the Royal Society of Chemistry, said he was “hugely pleased to see that the Nobel committee has chosen to honor two leading women in active research.” This year’s prize is the first time any science Nobel has gone to an all-female team. Many genome editors existed before CRISPR, but using them was time consuming, cumbersome, and expensive. CRISPR not only works with remarkable ease and speed, it is also the first editor that allows researchers to alter several genes in a single experiment. Rudolf Jaenisch of the Massachusetts Institute of Technology, whose group published one of the first studies of CRISPR-edited mice, said “any idiot can do it.” (Watch this story’s reporter fail at CRISPR, however.) Rodolphe Barrangou, a researcher at North Carolina State University who began to use bacteria’s CRISPR mechanism in 2007 to make yogurt cultures that were resistant to infection, says the prize is “a great opportunity to celebrate pioneers in the field.” Doudna and Charpentier, he says, “developed an amazing technology that enabled the scientific community and democratized genome editing.” He says before their work, “relatively few people cared about CRISPR.” Fyodor Urnov, a CRISPR researcher who works with Doudna, calls it “the most deserved Nobel Prize of the past 20 years.” Doudna’s and Charpentier’s discovery “changed everything for the better,” says Urnov, who previously worked on a more cumbersome gene editor called zinc fingers. “We can improve the world around us in extraordinary ways,” he says, noting that a CRISPR application has already cured a person of sickle cell disease. “The 21st century will be the age of CRISPR—thanks to Jennifer and Emmanuelle.” Related content from Science and Science AdvancesJinek et al., "A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity," Science 337, 6096 (17 Aug 2012) Brouns et al., "A Swiss Army Knife of Immunity," Science 337, 6096 (17 Aug 2012) Jinek et al., "Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation," Science 343, 6176 (14 Mar 2014) Doudna, Charpentier, "The new frontier of genome engineering with CRISPR-Cas9," Science 346, 6213 (28 Nov 2014) Baltimore et al., "A prudent path forward for genomic engineering and germline gene modification," Science 348, 6230 (3 Apr 2015) Taylor et al., "Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning," Science 348, 6234 (1 May 2015) Jiang et al., "A Cas9–guide RNA complex preorganized for target DNA recognition," Science 348, 6242 (26 Jun 2015) Knight et al., "Dynamics of CRISPR-Cas9 genome interrogation in living cells," Science 350, 6262 (13 Nov 2015) Jiang et al., "Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage," Science 351, 6275 (19 Feb 2016) Chen et al., "Cas9, poised for DNA cleavage," Science 351, 6275 (19 Feb 2016) Shin et al., "Disabling Cas9 by an anti-CRISPR DNA mimic," Science Advances 3, 7 (12 Jul 2017) Dagdas, "A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9," Science Advances 3, 8 (4 Aug 2017) G. Knott, J. Doudna, "CRISPR-Cas guides the future of genetic engineering," Science 361, 6405 (31 Aug 2018) S. Mao, V. Vinson, "Power couple: Science and technology," Science 361, 6405 (31 Aug 2018) Doudna, "CRISPR’s unwanted anniversary," Science 366, 6467 (15 Nov 2019) J. Hamilton, J. Doudna, "Knocking out barriers to engineered cell activity," Science 367, 6481 (28 Feb 2020) Lapinaite et al., "DNA capture by a CRISPR-Cas9–guided adenine base editor," Science 369, 6503 (31 Jul 2020) Related content from News from ScienceE. Pennisi, "Beyond TALENs," Science (14 Dec 2012) Sci. News Staff "Breakthrough of the year: The Runners-Up," Science (21 Dec 2012) E. Pennisi, "The CRISPR Craze," Science (23 Aug 2013) Sci. News Staff, "Breakthrough of the year: The Runners-Up–Genetic Microsurgery for the Masses," Science (20 Dec 2013) J. Travis, "Germline editing dominates DNA summit," Science (11 Dec 2015) J. Travis, "Making the cut," Science (18 Dec 2015) Sci. News Staff, "Science’s 2015 Breakthrough of the Year," Science (17 Dec 2005) M. McNutt, "Editorial: Breakthrough to genome editing," Science (18 Dec 2015) J. Cohen, "‘Base editors’ open new way to fix mutations," Science (27 Oct 2017) J. Couzin-Frankel, "CRISPR takes on cancer," Science (7 Feb 2020) |
URL | 查看原文 |
来源平台 | Science |
文献类型 | 新闻 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/297603 |
专题 | 资源环境科学 |
推荐引用方式 GB/T 7714 | admin. CRISPR, the revolutionary genetic ‘scissors,’ honored by Chemistry Nobel. 2020. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
查看访问统计 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[admin]的文章 |
百度学术 |
百度学术中相似的文章 |
[admin]的文章 |
必应学术 |
必应学术中相似的文章 |
[admin]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论